Alexander D. Macrae
Board Member
Sangamo Therapeutics, Inc (SGMOQ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alexander D. Macrae
Alexander D. Macrae is recorded as CEO and Board Member at Sangamo Therapeutics, Inc (SGMOQ). The proxy statement of Sangamo Therapeutics, Inc reports total compensation of $2,457,450 for Alexander D. Macrae in fiscal 2024, including a base salary of $716,366. Disclosed compensation is on record for 8 fiscal years. Alexander D. Macrae has spoken on 2 earnings calls across 1 company, most recently for Sangamo Therapeutics, Inc on August 7, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sangamo Therapeutics, Inc
Other people whose current roles at this company are on record from its filings.
- Kathy Y. Yi CFO
- Nikunj Jain CFO, Chief Accounting Officer
- Sung H. Lee CFO
- D. Mark McClung COO
- Scott B. Willoughby General Counsel
- Alexander D. Macrae, M.B., Ch.B., Ph.D. Board Member
- Courtney Beers Board Member
- Courtney Beers, Ph.D. Board Member
- Courtney Beers, PhD. Board Member
- Dr. John Markels Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Sangamo Therapeutics, Inc (SGMOQ) | Chief Executive Officer | $716,366 | $2,457,450 |
| 2023 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $716,366 | $2,392,272 |
| 2022 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $709,273 | $4,806,435 |
| 2021 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $688,615 | $4,735,817 |
| 2020 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $681,797 | $3,835,030 |
| 2019 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $661,939 | $3,986,555 |
| 2018 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $636,480 | $4,104,428 |
| 2017 | Sangamo Therapeutics, Inc (SGMOQ) | President and Chief Executive Officer | $612,000 | $1,795,856 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.